GLP-1 drugs like Ozempic may improve mood by altering gut microbiome, study suggests
By
Scott C. Anderson
Summary
Recent research from Southeast University in China, led by Honghong Yao, suggests that GLP-1 drugs like Ozempic may improve mood in depressed patients by altering the gut microbiome. The study connects the weight-loss effects of these drugs to changes in gut bacteria, which in turn influence brain chemistry and mood regulation. The findings imply that some of these antidepressant benefits might also be achievable through dietary changes that similarly impact the gut microbiome.
Source
Hacker NewsGLP-1 drugs like Ozempic may improve mood by altering gut microbiome, study suggestspsychologytoday.comKey quotes
· 3 pulledI've been taking Ozempic to lose weight but now I want to go hiking and play badminton with my friends.
Researchers rejoiced when Ozempic and other GLP-1 drugs worked to shed weight in their patients. But there was an unexpected bonus: Some depressed patients started to feel better.
They pieced together several related observations to solve the mystery.
You might also wanna read
What GLP-1 Drugs Reveal About the Brain's Compulsive Urges
GLP-1 medications (like Ozempic, Wegovy) are revealing insights about compulsive behavior beyond their effects on appetite. Patients report
mdsc.pe·4d ago
Why GLP-1 drugs like Ozempic cause oral health issues and how to manage them
The article explores the phenomenon of "Ozempic mouth" — oral health issues like bad breath, dry mouth, and dental changes associated with G
mdsc.pe·1d ago
Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels
A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy sign
gizmodo.com·13d ago
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr
gizmodo.com·29d ago
Systematic Review Finds GLP-1 Agonists Do Not Harm Male Fertility, May Offer Benefits
A systematic review presented at a medical conference found that GLP-1 agonists (like Ozempic, Wegovy) do not harm male fertility or the mal
mdsc.pe·6d ago
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two observational studies found that GLP-1 receptor agonists (like Ozempic, Wegovy) are associated with reduced breast cancer incidence in w
mdsc.pe·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.